Last update 01 Nov 2024

SpecGx LLC

Subsidiary Company|
Missouri, United States

Overview

Basic Info

Introduction
Specgx LLC, based in Missouri, functions as a pharmaceutical company and is a subsidiary of Mallinckrodt plc. The company offers a wide range of products covering fields such as neurology, rheumatology, nephrology, pulmonology, ophthalmology, immunotherapy. Further, it also provides products for neonatal respiratory critical care therapies, analgesics, and gastrointestinal issues. Geographically, Specgx LLC extends its services to clients in both the United States and Europe.

Tags

Other Diseases
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases4
Top 5 Drug TypeCount
Small molecule drug6
Top 5 TargetCount
DAT(Dopamine transporter)1
NET x SERT1
NMDA receptor x μ opioid receptor1
GABAA receptor(Gamma-aminobutyric acid A receptor)1
MATs(Monoamine transporters)1

Related

8
Drugs associated with SpecGx LLC
Oxycodone Hydrochloride
Target
Opioid receptors
Mechanism
Opioid receptors agonists
Active Org.
Protega Pharmaceuticals LLC [+5]
Originator Org.
Roxane Laboratories, Inc.Roxane Laboratories, Inc.
Active Indication
Cancer Pain [+1]
Inactive Indication
Acute Pain [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Oct 1998
Hydromorphone Hydrochloride
Target
μ opioid receptor
Mechanism
μ opioid receptor agonists
Active Org.
Rhodes Pharmaceuticals LPRhodes Pharmaceuticals LP [+8]
Originator Org.
Fresenius Kabi USA LLCFresenius Kabi USA LLC
Active Indication
Severe pain [+1]
Inactive Indication
Analgesia [+11]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date11 Jan 1984
Temazepam
Target
GABAA receptor
Mechanism
GABAA receptor agonists
Active Org.
SpecGx LLC [+1]
Originator Org.
Mallinckrodt PlcMallinckrodt Plc
Active Indication
Sleep Initiation and Maintenance Disorders
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date27 Feb 1981
100 Clinical Results associated with SpecGx LLC
Login to view more data
0 Patents (Medical) associated with SpecGx LLC
Login to view more data
100 Deals associated with SpecGx LLC
Login to view more data
100 Translational Medicine associated with SpecGx LLC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
6
2
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free